Assessment canadian coorindating health office technology jacksonville dating sites


18-Jul-2019 08:38

He has published on technologies for cancer, diabetes, rheumatic diseases, mental health, infectious diseases (HIV, hepatitis, and herpes zoster), care for the poor and underserved, and others.He has published seminal papers on the evaluation of genomic assays, clinical utility studies, and on the cost-effectiveness of specific assays.His interests centre around health technologies in health systems.

Note: At their June 21-22, 2005 meeting, the Federal/Provincial/Territorial Conference of Deputy Ministers of Health agreed to make the Advisory Committee on Information and Emerging Technologies dormant and with it all of its priorities. The Advisory Committee's mandate is to provide policy development and strategic advice on health information issues and on the effectiveness, appropriateness and utilization of emerging health products and technologies to the Conference of Federal, Provincial, and Territorial ( has a Provincial and Federal Co-chair and is comprised of representatives from the federal, provincial, and territorial governments as well as external members from Canada Health Infoway Inc., Canadian Coordinating Office on Health Technology Assessment, Canadian Institute for Health Information, and other external experts are added as the Committee deems necessary.He has served on various NIH scientific and economic advisory committees.Dev Menon received his Ph D and his Masters Health Services Administration from the University of Alberta, where he is professor of health policy and management.His research is published in leading clinical and policy journals (e.g. degree from the University of Rochester, New York and M. degree in Health Services Research from Stanford University.

Journal of the National Cancer Institute, Annals of Internal Medicine, JAMA) and his work is cited in international appraisals of new cancer technologies, such as the UK National Institute of Clinical Excellence and the Canadian Coordinating Office for Health Technology Assessment. Hornberger has provided Chief Medical Officer (CMO) consulting services, contributing to the strategy, development and implementation of innovative clinical programs/study designs that include collaboration with strategic business partners and academic institutes. Hornberger is Adjunct Clinical Professor of Medicine at Stanford University School of Medicine, supervising resident house staff in a clinic devoted to the care of the poor and underserved. He is past Co-Editor of Value in Health and is on the Editorial Board of Medical Decision Making.

Issues related to drugs will be addressed in the Committee’s Volume Six (October 2002).